Data / Medical devices / Germany / Roche Diagnostics GMBH
Roche Diagnostics GMBH: FDA-registered device maker in MANNHEIM Baden-Wurttemberg, Germany, 307 510(k) clearances and 22 PMA approvals
Roche Diagnostics GMBH is registered with the FDA (registration 9610126) in MANNHEIM Baden-Wurttemberg, Germany. It lists 273 device types. The FDA files 307 510(k) clearances and 22 PMA approvals under its listings, the newest dated October 20, 2026. Registered through 2027. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 9610126
- FEI number
- 3002806559
- Address
- Sandhofer Strasse 116, MANNHEIM Baden-Wurttemberg, Germany, D-68305
- Owner or operator
- Roche Diagnostics Operations Inc. (9039767)
- Roles
- Exporter to the US, Manufacturer, Repackager or relabeler, Specification developer
- First device listed
- June 1, 1983
- Registered through
- 2027
- Brand names listed
- 10X SSC, 579-2-RSA Dynamic Interface v1.1, 713-2-cobase 8100 v1.5, 770-1-CCM-AOB v1.1, ?-Amylase EPS ver.2, ?-Glutamyltransferase ver.2 - Standardized against IFCC / Szasz, ?-Glutamyltransferase ver.2-Standardized against IFCC/Szasz, A/C Inform II Base Unit Kit and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance. Newest 100 of 307.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| October 20, 2026 | DEN260027 | Elecsys HBsAg II quant II RxDx | SJM | Unknown | Roche Diagnostics | accessdata.fda.gov |
| August 19, 2026 | K261686 | Elecsys Phospho-Tau (217P) Plasma | SET | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| April 24, 2026 | K252431 | Elecsys Calcitonin | JKR | Substantially Equivalent | Roche Diagnostics GmbH | accessdata.fda.gov |
| April 13, 2026 | K252280 | Elecsys Anti-SARS-CoV-2 S | QVP | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| April 7, 2026 | K260049 | Elecsys Anti-HBc IgM | SEI | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| April 7, 2026 | K260048 | Elecsys Anti-HAV IgM | LOL | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| April 7, 2026 | K260046 | Elecsys Anti-HBc II | SEI | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| April 2, 2026 | K260026 | Tina-quant Cardiac high sensitivity CRP III | NQD | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| December 17, 2025 | K253839 | Elecsys Anti-SARS-CoV-2 | QVP | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| October 24, 2025 | K253188 | CoaguChek XS Plus System | GJS | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| October 8, 2025 | K252163 | Elecsys Phospho-Tau (181P) Plasma | SET | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| July 17, 2025 | K242505 | Elecsys Cortisol III | JFT | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| June 10, 2025 | K250768 | Elecsys Anti-SARS-CoV-2 | QVP | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| February 7, 2025 | K241453 | Elecsys sFlt-1 and Elecsys PlGF | QWH | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| January 24, 2025 | K241220 | Tina-quant Lipoprotein(a) Gen.2 Molarity | DFC | Substantially Equivalent | Roche Diagnostics Operations | accessdata.fda.gov |
| January 16, 2025 | K240197 | cobas® liat CT/NG/MG nucleic acid test | QEP | Substantially Equivalent | Roche Molecular Systems, Inc. | accessdata.fda.gov |
| March 22, 2024 | K231927 | Elecsys PTH , Elecsys PTH STAT | CEW | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| February 20, 2024 | K233454 | ONLINE TDM Methotrexate | LAO | Substantially Equivalent | Roche Diagnostics Operations | accessdata.fda.gov |
| September 30, 2023 | K221890 | Elecsys Tg II | MSW | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| September 15, 2023 | K222610 | Elecsys Anti-Tg | JZO | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| July 21, 2023 | K223637 | Elecsys proBNP II, Elecsys proBNP II STAT | NBC | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| June 5, 2023 | K231348 | Elecsys ß-Amyloid (1-42) CSF II, Elecsys Total-Tau CSF | QSE | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| April 7, 2023 | K220456 | Elecsys FT4 IV | CEC | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| March 30, 2023 | K230161 | ONLINE TDM Phenytoin - Free Phenytoin application | MOJ | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| January 4, 2023 | K221693 | Elecsys Anti-HCV II (08837031190) | MZO | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| December 23, 2022 | K221765 | ONLINE DAT Benzodiazepines II | JXM | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| December 7, 2022 | K221842 | Elecsys B-Amyloid (1-42) CSF II, Elecsys Phospho-Tau (181P) CSF | QSE | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| October 12, 2022 | K220924 | Elecsys HSV-2 IgG (08948887160) | MYF | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| October 12, 2022 | K220923 | Elecsys HSV-1 IgG (08948844160) | MXJ | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| October 12, 2022 | K220911 | Elecsys CMV IgG | LFZ | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| September 15, 2022 | K220176 | Elecsys AFP | LOJ | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| June 10, 2022 | K203757 | Elecsys AMH | PQO | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| May 6, 2022 | K211685 | Elecsys Testosterone II | CDZ | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| March 31, 2022 | K210546 | Elecsys proBNP II, Elecsys proBNP II STAT | NBC | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| September 21, 2021 | K201441 | Elecsys Troponin T Gen 5 | MMI | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| September 1, 2021 | K210901 | Elecsys Vitamin D total III | MRG | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| August 18, 2021 | K203227 | Elecsys HCG STAT | DHA | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| July 20, 2021 | K211302 | Elecsys Syphilis | LIP | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| July 30, 2020 | DEN200015 | cobas EBV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit | QLX | Unknown | Roche Molecular Systems, Inc. | accessdata.fda.gov |
| March 26, 2020 | K193053 | Tina-quant Hemoglobin A1cDx Gen.3 | PDJ | Substantially Equivalent | Roche Diagnostics Operations (Rdo) | accessdata.fda.gov |
| March 9, 2020 | K192815 | Elecsys BRAHMS PCT | PRI | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| February 27, 2020 | K193313 | Elecsys Anti-TSHR | JZO | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| February 21, 2020 | K192072 | Tina-quant C-Reactive Protein IV | DCN | Substantially Equivalent | Roche Diagnostics Operations (Rdo) | accessdata.fda.gov |
| August 16, 2019 | K191899 | Glucose HK Gen.3, ISE indirect Na for Gen.2, Elecsys TSH, cobas pro integrated solutions | CFR | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| August 13, 2019 | K190428 | Elecsys Anti-HAV II | LOL | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| May 7, 2019 | K183432 | cobas u 601 urinalysis test system | JIL | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| April 16, 2019 | K190773 | Elecsys TSH | JLW | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| February 8, 2019 | K183517 | Ammonia II | JIF | Substantially Equivalent | Roche Diagnostics Operations (Rdo) | accessdata.fda.gov |
| November 6, 2018 | K173857 | Elecsys Tacrolimus | MLM | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| November 5, 2018 | K182095 | Tina-quant Transferrin ver.2 (urine application) | DDG | Substantially Equivalent | Roche Diagnostics Operations (Rdo) | accessdata.fda.gov |
| July 6, 2018 | K173927 | Elecsys BRAHMS PCT | PRI | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| June 22, 2018 | K181492 | Elecsys CA 15-3 II | MOI | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| April 19, 2018 | K180693 | CoaguChek XS Pro System | GJS | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| April 19, 2018 | K180684 | CoaguChek XS Plus System | GJS | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| March 21, 2018 | K173887 | cobas CT/NG for use on cobas 6800/8800 systems | LSL | Substantially Equivalent | Roche Molecular Systems, Inc. | accessdata.fda.gov |
| February 20, 2018 | K171605 | Elecsys CA 15-3 II | MOI | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| December 25, 2017 | K170960 | CoaguChek Vantus System | GJS | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| September 12, 2017 | K171770 | cobas Cdiff Nucleic acid test for use on the cobas Liat System | OZN | Substantially Equivalent | Roche Molecular Systems, Inc. | accessdata.fda.gov |
| June 26, 2017 | K170416 | LZI Methadone Metabolite Enzyme Immunoassay, LZI Methadone Metabolite (100 and 300) Calibrators | DJR | Substantially Equivalent | Lin-Zhi International, Inc. | accessdata.fda.gov |
| June 23, 2017 | K162678 | Elecsys Toxo IgM, Elecsys Toxo IgM PreciControl | LGD | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| April 4, 2017 | K170678 | Beta-CrossLaps CalCheck 5 | JJX | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| March 17, 2017 | K163569 | Elecsys CMV IgM | LFZ | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| February 8, 2017 | K162840 | Elecsys Vitamin D total II, Vitamin D total II CalSet, PreciControl Vitamin D total II, Vitamin D CalCheck 5 | MRG | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| January 23, 2017 | K162606 | Elecsys TSH assay, cobas e 801 Immunoassay analyzer | JLW | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| January 18, 2017 | K162895 | Elecsys Troponin T Gen 5 STAT Assay, Elecsys Troponin T Gen 5 STAT CalSet, Elecsys PreciControl Troponin, Elecsys Troponin T Gen 5 CalCheck 5 | MMI | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| January 12, 2017 | K162173 | Elecsys CYFRA 21-1 CalCheck 5 | JJX | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| December 19, 2016 | K160571 | cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay | PDJ | Substantially Equivalent | Roche Diagnostics Operations (Rdo) | accessdata.fda.gov |
| December 19, 2016 | DEN150057 | Elecsys AMH, AMH CalSet, PreciControl AMH, AMH CalCheck 5 | PQO | Unknown | Roche Diagnostics | accessdata.fda.gov |
| December 14, 2016 | K160915 | Elecsys CYFRA 21-1, Elecsys CYFRA 21-1 CalSet, PreciControl Tumor Marker | OVK | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| October 19, 2016 | K162593 | HDL-Cholesterol Gen.4 | LBS | Substantially Equivalent | Roche Diagnostics Operations (Rdo) | accessdata.fda.gov |
| July 28, 2016 | K160910 | Elecsys Syphilis | LIP | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| July 27, 2016 | K161817 | Tina-quant Cystatin C Gen.2 | NDY | Substantially Equivalent | Roche Diagnostics Operations (Rdo) | accessdata.fda.gov |
| July 25, 2016 | K153544 | cobas Influenza A/B & RSV Nucleic Acid Test for Use on the cobas Liat System | OCC | Substantially Equivalent | Iquum, Inc. | accessdata.fda.gov |
| June 13, 2016 | K160729 | Elecys BRAHMS PCT, Elecys BRAHMS PCT CalCheck 5 | PMT | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| May 25, 2016 | K160570 | Creatine Kinase | JHS | Substantially Equivalent | Roche Diagnostics Operations (Rdo) | accessdata.fda.gov |
| April 27, 2016 | K152227 | Elecsys Cortisol II, Cortisol II CalSet | JFT | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| April 8, 2016 | K153301 | Elecsys Digoxin Immunoassay, Elecsys PreciControl Cardiac II | KXT | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| January 8, 2016 | K152245 | ONLINE TDM Vancomycin Gen.3 | LEH | Substantially Equivalent | Roche Diagnostics Operations (Rdo) | accessdata.fda.gov |
| October 22, 2015 | K151578 | Carbamazepine Gen 4 | KLT | Substantially Equivalent | Roche Diagnostics Operations (Rdo) | accessdata.fda.gov |
| October 2, 2015 | K152526 | Elecsys Progesterone III CalSet | JIT | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| September 24, 2015 | K151786 | Elecsys Vitamin B12 II assay, Elecsys Vitamin B12 II CalSet | CDD | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| August 6, 2015 | K143534 | Elecsys CA-125 II assay | LTK | Substantially Equivalent | Roche Professional Diagnostics | accessdata.fda.gov |
| June 1, 2015 | K150617 | cobas HSV 1 and 2 Test | OQO | Substantially Equivalent | Roche Molecular Systems, Inc. | accessdata.fda.gov |
| May 20, 2015 | K142422 | cobas Cdiff Test | OZN | Substantially Equivalent | Roche Molecular Systems, Inc. | accessdata.fda.gov |
| January 28, 2015 | K143691 | LDLC3 LDL-Cholesterol Gen.3 | LBR | Substantially Equivalent | Roche Diagnostics Operations (Rdo) | accessdata.fda.gov |
| December 19, 2014 | K143342 | Elecsys T-Uptake Calset | JIT | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| December 17, 2014 | K142721 | cobas MRSA/SA Test | NQX | Substantially Equivalent | Roche Molecular Systems, Inc. | accessdata.fda.gov |
| December 9, 2014 | K141925 | TOTAL PROTEIN URINE/CSF GEN.3 | JIQ | Substantially Equivalent | Roche Diagnostics Operations (Rdo) | accessdata.fda.gov |
| November 25, 2014 | K141928 | COBAS C ACETAMINOPHEN GEN.2 ASSAY, ACET2 CALIBRATOR | DKB | Substantially Equivalent | Roche Diagnostics Operations (Rdo) | accessdata.fda.gov |
| November 4, 2014 | K141338 | LIAT STREP A ASSAY | PGX | Substantially Equivalent | Iquum, Inc. | accessdata.fda.gov |
| October 24, 2014 | K142133 | ELECYS CMV IGM IMMUNOASSAY; ELECYS PRECICONTROL CMV IGM | LFZ | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| October 17, 2014 | K141426 | ELECSYS FOLATE III | CGN | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| August 12, 2014 | K142021 | Elecsys Estradiol III CalSet | JIT | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| July 17, 2014 | K141143 | COBAS C TINA-QUANT CYSTATIN C GEN.2 ASSAY, C.F.A.S. CYSTATIN C CALIBRATOR, CYSTATIN C GEN.2 CONTROL SET | NDY | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| June 6, 2014 | K140112 | CA 125 II CALSET II | JIT | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| May 8, 2014 | K140404 | ELECSYS CK-MB STAT IMMUNOASSAY | JHY | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| February 28, 2014 | K131605 | ELECSYS PRECICONTROL CMV IGG, ELECSYS CMV IGG IMMUNOASSAY | LFZ | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| January 27, 2014 | K131244 | ELECSYS FT4 II ASSAY, ELECSYS FT4 II CALSET | CEC | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| December 4, 2013 | K132828 | ELECSYS CALCITONIN; IMMUNOASSAY, CALSET, CALCHECK 5; ELECSYS PRECICONTROL VARIA 3 | JKR | Substantially Equivalent | Roche Diagnostics | accessdata.fda.gov |
| December 2, 2013 | K132270 | COBAS CT/NG V2.0 TEST | LSL | Substantially Equivalent | Roche Molecular Systems, Inc. | accessdata.fda.gov |
PMA approvals
Premarket approvals this establishment lists, with the supplements the FDA has decided since.
| Approved | PMA number | Device | Product code | Supplements | Latest decision | Source |
|---|---|---|---|---|---|---|
| February 23, 2021 | P190034 | Elecsys Anti-HBs II, PreciControl Anti-HBs, Anti-HBs CalCheck | SEI | 10 | May 22, 2025 | accessdata.fda.gov |
| February 3, 2021 | P190005 | Elecsys Anti-HBe, PreciControl Anti-HBe | SEI | 7 | May 22, 2025 | accessdata.fda.gov |
| June 18, 2020 | P200014 | cobas® EZH2 Mutation Test | OWD | 10 | March 17, 2026 | accessdata.fda.gov |
| June 1, 2017 | P160041 | COBAS CMV | PAB | 46 | October 10, 2024 | accessdata.fda.gov |
| December 23, 2016 | P160019 | Elecsys HBsAg II/Elecsys HBsAg Confirmatory Test/ PreciControl HBsAg II | LOM | 19 | May 22, 2025 | accessdata.fda.gov |
| October 14, 2015 | P150015 | COBAS HCV TEST | MZP | 42 | June 2, 2021 | accessdata.fda.gov |
| October 14, 2015 | P150014 | COBAS HBV TEST | MKT | 57 | October 17, 2025 | accessdata.fda.gov |
| June 11, 2015 | P140021 | ELECSYS ANTI-HCV II IMMUNOASSAY, ELECSYS PRECICONTROL ANTI-HCV | MZO | 16 | April 24, 2019 | accessdata.fda.gov |
| March 14, 2014 | P130015 | ELECSYS® HBEAG IMMUNOASSAY AND ELECSYS® PRECICONTROL HBEAG | LOM | 22 | May 22, 2025 | accessdata.fda.gov |
| October 26, 2011 | P110022 | ELECSYS ANTI-HBC IGM IMMUNOASSAY AND ELECSYS PRECICONTROL ANTI-HBC IGM | SEI | 32 | May 22, 2025 | accessdata.fda.gov |
| August 17, 2011 | P110020 | COBAS 4800 BRAF V600 MUTATION TEST | OWD | 44 | March 17, 2026 | accessdata.fda.gov |
| June 27, 2011 | P100032 | ELECSYS ANTI-HBC IMMUNOASSAY, ELECSYS PRECICONTROL ANTI-HBC FOR USE ON THE ELECSYS 2010 IMMUNOASSAY ANALYZER | SEI | 22 | May 22, 2025 | accessdata.fda.gov |
| June 22, 2011 | P100031 | ELECSYS ANTI-HBC IMMUNOASSAY & ELECSYS PRECICONTROL ANTI-HBC | SEI | 31 | May 22, 2025 | accessdata.fda.gov |
| April 19, 2011 | P100020 | COBAS HPV TEST | MAQ | 64 | March 17, 2026 | accessdata.fda.gov |
| April 29, 2010 | P090008 | ELECSYS ANTI-HCV IMMUNOASSAY & ELECSYS PRECICONTROL ANTI-HCV FOR USE ON COBAS E601 IMMUNOSSAY ANALYZER | MZO | 20 | April 24, 2019 | accessdata.fda.gov |
| September 4, 2008 | P050028 | COBAS TAQMAN HBV TEST | MKT | 88 | October 4, 2024 | accessdata.fda.gov |
| February 28, 2002 | P010054 | ELECSYS ANTI-HBS | SEI | 45 | May 22, 2025 | accessdata.fda.gov |
| July 3, 2001 | P000012 | COBAS AMPLICOR (TM) HEPATITIS C VIRUS (HCV) TEST, V2.0 | MZP | 51 | August 4, 2016 | accessdata.fda.gov |
| June 1, 2001 | P990012 | ELECSYS HBSAG IMMUNOASSAY, ELECSYS HBSAG CONFIRMATORY, AND PRECICONTROL HBSAG | LOM | 30 | April 24, 2019 | accessdata.fda.gov |
| December 12, 2000 | P000027 | ELECSYS FREE PSA IMMUNOASSAY/CALSET/CALCHECK | LTJ | 42 | April 29, 2026 | accessdata.fda.gov |
| November 22, 2000 | P990056 | ELECSYS TOTAL PSA IMMUNOASSAY AND TOTAL PSA CALSET | MTF | 43 | April 29, 2026 | accessdata.fda.gov |
| October 2, 1996 | P920031 | EMIT 2000 CYCLOSPORINE SPECIFIC ASSAY | MKW | 3 | July 24, 2002 | accessdata.fda.gov |
Compare with other makers
- All makers of Multi-Analyte Controls, All Kinds (Assayed)
- All makers of Real Time Nucleic Acid Amplification System
- All makers of C. Difficile Toxin Gene Amplification Assay
- All makers of Titrimetric With Edta And Indicator, Calcium
- All makers of Enzyme Linked Immunoabsorption Assay, Treponema Pallidum
- All makers of Procalcitonin Assay
Updated October 20, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.